Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2016-04-14 Investor Presentation
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
关于举行2015年度业绩网上说明会的通知
Investor Presentation Classification · 90% confidence The document is a notice about holding an online performance explanation meeting for the 2015 fiscal year results. It mentions the date and time of the meeting and invites investors to participate. The document does not contain actual financial data or detailed financial statements but rather announces an event related to discussing the annual performance. The document length is short (604 characters), and it serves as an announcement for an investor presentation rather than the presentation or report itself. Therefore, the most appropriate classification is Investor Presentation (IP).
2016-04-14 Chinese
监事会关于公司《2015年内部控制自我评价报告》审核意见
Audit Report / Information Classification · 95% confidence The document is a supervisory board's audit opinion on the company's 2015 Internal Control Self-Evaluation Report. It discusses the internal control system, its completeness, and the board's confirmation of the report's accuracy and objectivity. The document is short (500 characters) and serves as an opinion or certification rather than the full internal control report itself. It does not contain detailed financial data or comprehensive report content. Therefore, it fits best under Audit Report / Information (AR), which includes audit opinions and applied accounting principles related to internal controls, excluding full annual reports. FY 2015
2016-04-14 Chinese
东海证券股份有限公司关于公司2015年度内部控制自我评价报告的核查意见
Audit Report / Information Classification · 95% confidence The document is titled as an opinion on the 2015 internal control self-evaluation report of a company, issued by a securities firm acting as a sponsor. It discusses the verification work done by the sponsor on the internal control report, governance structure, organizational structure, production and management, fundraising management, and other management processes. The document provides an audit opinion on the internal control report but does not contain the full internal control report itself or detailed financial statements. The document length is 2724 characters, which is relatively short and consistent with an opinion or verification letter rather than a full report. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit opinion on internal controls, not a full annual report or interim report. Therefore, the correct classification is AR with high confidence. FY 2015
2016-04-14 Chinese
关于公司控股股东及其他关联方资金占用情况汇总表的专项审核报告
Audit Report / Information Classification · 95% confidence The document is titled as a "专项审核报告" (Special Audit Report) regarding the summary table of funds occupied by controlling shareholders and other related parties for the year 2015. It references auditing standards and the responsibilities of management and auditors. The content includes detailed financial data about related party transactions and fund occupation, with audit opinions and tables. The document is not a full annual report but a standalone audit report focusing on a specific issue related to related party fund occupation. It is not an announcement or a certification letter but an actual audit report with substantive financial data and audit conclusions. Therefore, it fits the category of Audit Report / Information (AR). The document length is under 5,000 characters but contains detailed audit findings and tables, so it is not a mere announcement or publication notice. FY 2015
2016-04-14 Chinese
董事会关于募集资金年度存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report from the board of directors of a company (葵花药业集团股份有限公司) regarding the annual status of funds raised through a capital raising event. It includes specifics on the amount raised, timing, usage, management, and storage of the funds, as well as tables showing the use of funds during the fiscal year 2015. The document references regulatory approvals, audit verification reports, and compliance with securities laws and stock exchange regulations. The content focuses on the management and use of capital raised, which aligns with a Capital/Financing Update. It is not an annual report, earnings release, or other financial statement but a specialized report on the use of raised capital funds. The document length is over 5,000 characters and contains substantive financial data related to capital usage, so it is not a mere announcement or certification. Therefore, the best fitting category is Capital/Financing Update (CAP).
2016-04-14 Chinese
第二届监事会第十二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of a company regarding the review and approval of various reports and proposals related to the 2015 fiscal year, including the Supervisory Board's work report, the full annual report and summary, the financial statements, profit distribution plan, internal control reports, and related party transactions. It includes voting results and states that these items will be submitted to the 2015 Annual General Meeting for approval. The document does not contain the full annual report itself but rather the Supervisory Board's resolutions and approvals of these reports and proposals. The document length is 3090 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement of Supervisory Board resolutions related to the annual report and financial statements, not the full annual report itself.
2016-04-14 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.